Abstract
Antibodies to endothelial cells may be involved in the pathogenesis of vasculitic disorders. In view of recent evidence implicating intestinal vascular injury in the pathogenesis of inflammatory bowel disease, we have sought anti-endothelial cell antibodies in affected patients, examined their relationship to vascular injury, and tested their ability to mediate endothelial cell cytotoxicityin vitro. Anti-endothelial cell antibody levels were elevated in ulcerative colitis (P<0.0001) and Crohn's disease (P<0.05) compared with healthy controls. In ulcerative colitis, anti-endothelial cell antibody levels were related to disease activity and correlated with circulating levels of von Willebrand factor (r=0.58,P<0.01), a marker of vascular injury. Anti-endothelial cell antibodies, however, were not directly cytotoxic to endothelial cellsin vitro. These data indicate, for the first time, an association between anti-endothelial cell antibody levels and vascular injuryin vivo and suggest that they may be important in the pathogenesis of inflammatory bowel disease, particularly ulcerative colitis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RM, Lewis AAM, Pounder RE: Pathogenesis of Crohn's disease: Multifocal gastrointestinal infarction. Lancet 2:1057–1062, 1989
Fairburn RA: On the aetiology of ulcerative colitis: A vascular hypothesis. Lancet 1:697–699, 1973
Donnellan WL: Early histological changes in ulcerative colitis: A light and electron microscopic study. Gastroenterology 50:519–540, 1966
Wakefield AJ, Sankey EA, Dhillon AP, Sawyerr AM, More L, Sim R, Pitillo M, Rowles PM, Hudson M, Adam A, Lewis AM, Pounder RE: Granulomatous vasculitis in Crohn's disease. Gastroenterology 100:1279–1278, 1991
Stevens TRJ, James JP, Simmonds NJ, McCarthy DA, Laurensen IF, Maddison PJ, Rampton DS: Circulating von Willebrand factor in inflammatory bowel disease. Gut 33:502–506, 1992
Leung DYM, Collins T, Lapierre LA, Geha RS, Pober JS: Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest 77:1428–1435, 1986
Tannenbaum SH, Finko R, Cines DB: Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol 137:1532–1537, 1986
Saxon A, Shanahan F, Landers C, Gantz T, Targan S: A distinct subset of anti-neutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 86:202–210, 1990
Cambridge G, Rampton DS, Stevens TRJ, McCarthy DA, Kamm MA, Leaker B: Anti-neutrophil antibodies in inflammatory bowel disease. Gut 33:668–674, 1992
Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from human umbilical veins. J Clin Invest 52:2745–2756, 1973
Vismara A, Meroni PL, Tincani A, Harris EN, Barcellini W, Brucato A, Khamashta M, Hughes GRV, Zanussi C, Balestrieri G: Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol 74:247–253, 1988
Varley H, Gowenlock AH, Bell M: Practical Clinical Biochemistry, Vol 1, General Topics and Commoner Tests. London, W. Heinemann Medical Books, 1980, pp 290, 313, 351
Pober JS, Gimbrone MA, Cotran RS, Reiss CS, Burakoff SJ, Fiers W, Ault KA: Ia expression by vascular endothelium is inducible by activated T-cells and by human interferon. J Exp Med 157:1339–1353, 1983
Frampton G, Jayne DRW, Perry GJ, Lockwood CM, Cameron JS: Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol 82:227–232, 1991
McCarthy D, Goddard DH, Holborrow EJ, Horsfall AC, Mumford PA, Maini RN: The effect of IgG aggregate size and concentration on reactivity in immune complex assays. J Immunol Methods 47:349–353, 1981
James JP, Stevens TRJ, Hall ND, Maddison PJ, Goulding NJ, Silman A, Holligan S, Black C: Factor VIII-related antigen in connective tissue disease patients and relatives. Br J Rheumatol 29:6–9, 1990
Collins T, Krensky AM, Clayberger C, Fiers W, Gimbrone MA, Burakoff SJ, Pober JS: Human cytotoxic T-lymphocyte interactions with vascular endothelium and fibroblasts: Role of effector and target cell molecules. J Immunol 84:1878–1884, 1984
Sawyerr AM, Pottinger BE, Wakefield AJ, Pearson JD, Hudson M, Brooks C, Pounder RE: Serum anti-endothelial cell antibodies are present in Crohn's disease, but not ulcerative colitis. Gut 31:A1169, 1990
Pober JS, Gimbrone MA: Expression of Ia-like antigens by human vascular endothelial cells is induciblein vitro: Demonstration by monoclonal antibody binding and immunoprecipitation. Proc Natl Acad Sci USA 79:6641–6645, 1982
Shingu M, Hashimoto Y, Johnson AR, Hurd ER: The search for Fc receptors on human tissues and human endothelial cells in culture. Proc Soc Exp Biol Med 167:147–152, 1981
Lawley TJ, James SP, Jones EA: Circulating immune complexes: Their detection and potential significance in some hepatobiliary and intestinal diseases. Gastroenterology 78:626–641, 1978
Cines DB, Lyss AP, Reeber M, Bina M, DeHoratius RJ: Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J. Clin Invest 73:611–617, 1984
Falk RJ, Terrell RS, Charles LA, Jennette JC: Antineutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87:4115–4119, 1990
Falk RJ, Jennette JC: Anti-neutrophil cytoplasmic antibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and cresentic glomerulonephritis. N Engl J Med 318:1651–1657, 1989
Unkeless JC: Function and heterogeneity of human Fc receptors for immunoglobulin G. J Clin Invest 83:355–361, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stevens, T.R.J., Harley, S.L., Groom, J.S. et al. Anti-endothelial cell antibodies in inflammatory bowel disease. Digest Dis Sci 38, 426–432 (1993). https://doi.org/10.1007/BF01316494
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01316494